Pharvaris PHVS
NASDAQ PHVS
$30.92 +1.15 (+3.86%)
As of: Oct 20, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Other Operating Expenses (2021 - 2025)

Updated

Pharvaris (PHVS) posted Other Operating Expenses of $0.00 for Q3 2025.

Analysis

Pharvaris (PHVS) Other Operating Expenses (2021 - 2025) Analysis & Trends

For FY2018, Pharvaris' Other Operating Expenses came in at -$4.31 trillion.

  • The Q3 2025 figure stands as the highest quarterly Other Operating Expenses since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Pharvaris 1.83 Bn 451.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Dec 31, 2024 0.00
Mar 31, 2024 0.00
Sep 30, 2022 0.00
Mar 31, 2022 0.00
Sep 30, 2021 0.00
API Access

Pharvaris Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=PHVS&period=max&api_key=YOUR_API_KEY